Suzanne T. Ildstad, M.D. - Publications

Affiliations: 
 

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Leventhal JR, Ildstad ST. Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Facilitating Cell-Enriched Donor Stem Cell Infusion: the importance of durable chimerism. Human Immunology. PMID 29409743 DOI: 10.1016/j.humimm.2018.01.007  0.301
2017 Chhabra AY, Leventhal J, Merchak AR, Ildstad S. HSCT-Based Approaches for Tolerance Induction in Renal Transplant. Transplantation. 101: 2682-2690. PMID 28574903 DOI: 10.1097/TP.0000000000001837  0.305
2013 Leventhal JR, Mathew JM, Ildstad S, Salomon DR, Kurian SM, Suthanthiran M, Tambur A, Friedewald J, Gallon L, Charette J, Levitsky J, Kanwar Y, Abecassis M, Miller J. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance Clinical Transplants. 145-156. PMID 25095503  0.305
2013 Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST. Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance. Clinical Pharmacology and Therapeutics. 93: 36-45. PMID 23212110 DOI: 10.1038/Clpt.2012.201  0.302
2012 Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud DJ, King B, Elliott MJ, Herzig G, Herzig R, Ildstad ST. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Science Translational Medicine. 4: 124ra28. PMID 22399264 DOI: 10.1126/Scitranslmed.3003509  0.303
2011 Cardenas PA, Huang Y, Ildstad ST. The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation. Chimerism. 2: 65-70. PMID 22163063 DOI: 10.4161/chim.2.3.17588  0.322
2007 Colson YL, Shinde Patil VR, Ildstad ST. Facilitating cells: novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD. Critical Reviews in Oncology/Hematology. 61: 26-43. PMID 17150368 DOI: 10.1016/j.critrevonc.2006.06.011  0.323
2004 Colson YL, Xu H, Huang Y, Ildstad ST. Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts. Journal of Immunology (Baltimore, Md. : 1950). 173: 5827-34. PMID 15494536 DOI: 10.4049/jimmunol.173.9.5827  0.305
2004 Xu H, Chilton PM, Huang Y, Schanie CL, Ildstad ST. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. Journal of Immunology (Baltimore, Md. : 1950). 172: 1463-71. PMID 14734723 DOI: 10.4049/jimmunol.172.3.1463  0.302
2003 Jacquet EG, Schanie CL, Fugier-Vivier I, Willer SS, Ildstad ST. Facilitating cells as a venue to establish mixed chimerism and tolerance. Pediatric Transplantation. 7: 348-57. PMID 14738294 DOI: 10.1034/j.1399-3046.2003.00100.x  0.323
2001 Chilton PM, Huang Y, Ildstad ST. Bone marrow cell graft engineering: from bench to bedside. Leukemia & Lymphoma. 41: 19-34. PMID 11342354 DOI: 10.3109/10428190109057951  0.309
1999 Exner BG, Domenick MA, Bergheim M, Mueller YM, Ildstad ST. Clinical applications of mixed chimerism. Annals of the New York Academy of Sciences. 872: 377-85; discussion 3. PMID 10372140 DOI: 10.1111/j.1749-6632.1999.tb08482.x  0.306
1999 Exner BG, Acholonu IN, Bergheim M, Mueller YM, Ildstad ST. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts. Acta Haematologica. 101: 78-81. PMID 10202237  0.304
1997 Exner BG, Colson YL, Li H, Ildstad ST. In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning Surgery. 122: 221-227. PMID 9288126 DOI: 10.1016/S0039-6060(97)90012-X  0.311
1997 Jankowski RA, Ildstad ST. Chimerism and tolerance: From freemartin cattle and neonatal mice to humans Human Immunology. 52: 155-161. PMID 9077564 DOI: 10.1016/S0198-8859(96)00290-X  0.33
1996 Colson YL, Li H, Boggs SS, Patrene KD, Johnson PC, Ildstad ST. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. Journal of Immunology (Baltimore, Md. : 1950). 157: 2820-9. PMID 8816385  0.304
1995 Li H, Abou El-Ezz AY, Gambrell BE, Ildstad ST. Mixed xenogeneic chimerism and tolerance III: A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts Transplantation. 60: 59-65. PMID 7624944  0.306
1995 Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. Journal of Immunology (Baltimore, Md. : 1950). 155: 4179-88. PMID 7594573  0.319
1995 Colson YL, Zadach K, Nalesnik M, Ildstad ST. Mixed allogeneic chimerism in the rat: Donor - Specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts Transplantation. 60: 971-980. PMID 7491703  0.304
1993 Cooper MH, Nalesnik MA, Watkins SC, Hoffman RA, Ildstad ST. Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response Transplantation. 56: 934-940. PMID 8212220  0.32
1992 Wren SM, Hronakes ML, Ildstad ST. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A + B→A) to secondary recipients Transplantation. 54: 1031-1040. PMID 1465769  0.313
1991 Wren SM, Nalesnik M, Hronakes ML, Oh E, Ildstad ST. Mixed chimerism to induce tolerance for solid organ transplantation Journal of Pediatric Surgery. 26: 439-443. PMID 2056405 DOI: 10.1016/0022-3468(91)90992-3  0.311
1986 Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2 → B10) Journal of Immunology. 136: 28-33. PMID 2933464  0.303
Show low-probability matches.